Lee Sung-Bum, Lee Hui-Jeong, Ryu Ha Eun, Park Byoungjin, Jung Dong-Hyuk
Department of Family Medicine, Soonchunhyang University Bucheon Hospital, Bucheon-si 22972, Republic of Korea.
Department of Family Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Biomedicines. 2023 Aug 7;11(8):2212. doi: 10.3390/biomedicines11082212.
Several studies have showed that hyperuricemia is related to the development of ischemic heart disease (IHD). There is also growing evidence indicating that hyperuricemia may contribute to the progression of IHD as a pathogenic factor. Ironically, uric acid can be an antioxidant agent, as shown in experimental studies. The aim of our study is to analyse the association between uric acid and IHD with early-stage chronic kidney disease (CKD). Data were assessed from 17,492 participants without cardiovascular disease from the Korean Genome and Epidemiology Study (KoGES) and Korea Health Insurance Review and Assessment (HIRA) data. The subjects were categorized as four groups according to CKD and uric acid levels. We retrospectively evaluated hazard ratios (HRs) with 95% confidence intervals (CIs) for IHD by using multivariate Cox regression analysis over a 4-year period from the baseline survey. During the follow-up, 335 individuals (3.4%; 236 men and 99 women) developed IHD. Compared to the participants without elevated uric acid and early CKD HRs for incident IHD according to uric acid levels and early CKD, the uric acid level was 1.13 (95% CI, 0.86-1.48) in participants with elevated uric acid and without early CKD, 0.99 (95% CI, 0.55-1.77) in participants without elevated uric acid and with early CKD, and 1.65 (95% CI, 1.03-2.66) in participants with elevated uric acid and early CKD after adjusting for confounding metabolic factors. Early CKD and high uric acid levels increased the risk of new-onset IHD (HR, 1.65; 95% CI, 1.03-2.66). Elevated uric acid levels were related to an increased risk of incident IHD in early-stage CKD patients. It is expected that uric acid can be a reliable predictor for IHD, even in early-stage CKD patients; thus, in those with CKD, proactively managing uric acid levels can play a significant role in reducing the risk of cardiovascular disease.
多项研究表明,高尿酸血症与缺血性心脏病(IHD)的发生有关。越来越多的证据表明,高尿酸血症可能作为一种致病因素促进IHD的进展。具有讽刺意味的是,如实验研究所示,尿酸可以是一种抗氧化剂。我们研究的目的是分析尿酸与伴有早期慢性肾脏病(CKD)的IHD之间的关联。数据来自韩国基因组与流行病学研究(KoGES)和韩国健康保险审查与评估(HIRA)数据中17492名无心血管疾病的参与者。根据CKD和尿酸水平将受试者分为四组。我们通过多变量Cox回归分析,在基线调查后的4年期间回顾性评估IHD的风险比(HRs)及95%置信区间(CIs)。在随访期间,335人(3.4%;236名男性和99名女性)发生了IHD。与尿酸未升高且无早期CKD的参与者相比,根据尿酸水平和早期CKD,尿酸升高但无早期CKD的参与者发生IHD的HR为1.13(95%CI,0.86 - 1.48),尿酸未升高但有早期CKD的参与者为0.99(95%CI,0.55 - 1.77),在调整混杂代谢因素后,尿酸升高且有早期CKD的参与者为1.65(95%CI,1.03 - 2.66)。早期CKD和高尿酸水平增加了新发IHD的风险(HR,1.65;95%CI,1.03 - 2.66)。尿酸水平升高与早期CKD患者发生IHD的风险增加有关。预计尿酸即使在早期CKD患者中也可以是IHD的可靠预测指标;因此,在患有CKD的患者中,积极控制尿酸水平对降低心血管疾病风险可发挥重要作用。